Zevra Therapeutics Inc.
ZVRA | NASDAQ
$11.67
+$0.06 (+0.52%)
At close: Sep 21, 2026, 4:00 PM ET
$11.80
+$0.13 (+1.11%)
Pre-market:
Sep 22, 2026, 7:23 AM ET
Market Data
Market Cap $689.87M
Enterprise Value $468.3M
Beta 0.95
Average Volume 1.57M
Shares Outstanding (Diluted) 61.34M
Shares Change YoY 8.9%
Institutional Ownership 70.74%
Exchange NASDAQ
ISIN US4884452065
Price Performance
Price Change 1M -1.9%
Price Change 3M -10.2%
Price Change 6M 27.8%
Price Change YTD 39.9%
Price Change 1Y 46.8%
Price Change 3Y 140.1%
Price Change 5Y 28.2%
1M CAGR (ann.) 0.9%
1Y CAGR (ann.) 47.0%
5Y CAGR (ann.) 5.4%
All-Time CAGR -21.2%
Valuation
PE Ratio 12.55
Forward PE 10.51
PEG Ratio 0.01
Forward PEG -0.78
PS Ratio 5.07
Forward PS 3.90
PB Ratio 3.17
P/FCF Ratio 17.81
P/Adj. FCF Ratio 30.67
P/OCF Ratio 20.84
EV/Sales 3.44
EV/EBIT 6.54
EV/EBITDA 6.41
EV/FCF 12.09
Earnings Yield 8.0%
FCF Yield 5.6%
Adj. FCF Yield 3.3%
Financial Health
Net Cash $221.57M
Total Debt $0
Cash & Short-Term Investments $221.57M
Total Assets $302.71M
Current Ratio 5.17
Quick Ratio 5.12
Debt / Equity Ratio 0.01
Debt / EBITDA 0.00
Debt / FCF 0.00
OCF / Debt N/A
Interest Coverage 6.84
Altman Z-Score 5.16
Piotroski F-Score 6
Margins & Profitability
Gross Profit Margin 95.0%
Operating Profit Margin 28.7%
EBITDA Margin 53.7%
Net Profit Margin 42.8%
FCF Margin 28.5%
Adj. FCF Margin 16.5%
SBC / Revenue 9.7%
SBC Impact (per share) -41.9%
Returns
Return on Assets 19.3%
Return on Equity 32.8%
Return on Invested Capital 12.9%
Return on Capital Employed 15.4%
Return on Tangible Assets 19.9%
Historical Growth (CAGR)
Revenue CAGR 3Y 100.7%
Revenue CAGR 5Y 36.8%
Revenue CAGR 10Y 35.4%
EPS CAGR 3Y 532.3%
EPS CAGR 5Y 89.1%
EPS CAGR 10Y 41.7%
FCF CAGR 3Y 222.4%
FCF CAGR 5Y 26.8%
FCF CAGR 10Y 14.0%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 10
EPS Growth Next 3Y 26.4%
Revenue Growth Next 3Y 25.1%
Earnings Date Nov 3, 2026
EPS Estimate (next Q) $0.14
EPS Growth Est (next Q) -1500.0%
Revenue Est (next Q) $37.08M
Revenue Growth Est (next Q) 42.3%
Fair Value Estimates
Graham Number $8.78
Graham Upside -24.8%
Lynch Fair Value $23.25
Lynch Upside 99.2%
Price Target $25.75
Price Target Upside 120.7%
Cash Flow
Operating Cash Flow $39.54M
Free Cash Flow $38.73M
Adj. Free Cash Flow $22.5M
FCF Per Share $0.55
OCF Per Share $0.56
OCF/S Ratio 24.5%
Income Statement
Revenue $136.07M
Gross Profit $129.21M
Operating Income $39.07M
EBITDA $73.01M
Net Income $58.26M
EPS (Diluted) $0.93
Revenue / Employee $2.23M
Profit / Employee $955.13K
Employees 61
Add to Watchlist
Select watchlists to add or remove ZVRA